This excerpt taken from the AMCC DEF 14A filed Jul 2, 2007.
Director Compensation
The following table
provides information concerning the compensation earned by our non-employee directors for the fiscal year ended March 31, 2007:
Name
Fees Earned or Paid in Cash ($)
Option Awards
(2)(3)(4) ($)
Total ($)
Cesar Cesaratto
87,500
117,202
204,702
Neil Ransom, Ph.D.
31,419
7,489
38,908
Fred Shlapak
24,548
29,892
54,440
Arthur B. Stabenow
83,500
96,792
180,292
Julie H. Sullivan, Ph.D.
52,464
140,052
192,516
Murray A. Goldman, Ph.D.(1)
24,819
130,503
155,322
Harvey P. White(1)
71,830
97,183
169,013
David B. Wright(1)
24,819
155,920
180,739
(1)
Dr. Goldman and Messrs. White and Wrights terms as directors ended at our fiscal 2006 annual meeting of stockholders, which was held on March 9, 2007.
(2)
The amounts shown represent the compensation expense recognized by us in fiscal 2007 for stock options granted to the non-employee directors during fiscal 2007 and in prior years
that continued to vest during fiscal 2007, in accordance with SFAS No. 123(R). We use the Black-Scholes pricing model to calculate stock-based compensation expense under SFAS No. 123(R). For more information regarding the assumptions used
in determining compensation expense under SFAS No. 123(R), see note 1 to our consolidated financial statements included in our fiscal 2007 Annual Report on Form 10-K.
(3)
The aggregate number of shares subject to stock option awards outstanding as of March 31, 2007 was 320,000, 75,000, 75,000, 400,000, 125,000, 89,583, 495,833 and 102,083 for
Mr. Cesaratto, Dr. Ransom, Mr. Shlapak, Mr. Stabenow, Dr. Sullivan, Dr. Goldman, Mr. White and Mr. Wright, respectively.
38
(4)
The following table sets forth the full grant date fair value of each stock option award reported in the table above, as calculated under SFAS No. 123(R):